Intangible Assets (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Mar. 19, 2018 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Amortization expense | $ 795,328 | $ 795,328 | |
| Future amortization expense | $ 790,000 | $ 788,000 | |
| Common stock shares issued | 14,187,984 | 5,486,595 | |
| Common stock shares outstanding | 14,187,984 | 5,486,595 | |
| CoNCERT Pharmaceuticals, Inc [Member] | License Rights [Member] | |||
| Purchase price | $ 8,000,000 | ||
| Transaction cost | 1,782 | ||
| Recognition of deferred tax liability | 3,037,147 | ||
| Intangible asset, tax basis | $ 1,782 | ||
| Number of shares distributed in exchange for license agreement | 298,615 | ||
| Shares acquired price per share | $ 26.79 | ||
| Common stock shares issued | 5,039,033 | ||
| Common stock shares outstanding | 5,039,033 | ||
| X | ||||||||||
- Definition Intangible asset, tax basis. No definition available.
|
| X | ||||||||||
- Definition Number of shares distributed in exchange for license agreement. No definition available.
|
| X | ||||||||||
- Definition Purchase price of inyangible assets. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. No definition available.
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. No definition available.
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|